AR118674A1 - Proceso para la producción de derivados de 2-[2-(fenil)etilamino]alcanamida sustituidos - Google Patents

Proceso para la producción de derivados de 2-[2-(fenil)etilamino]alcanamida sustituidos

Info

Publication number
AR118674A1
AR118674A1 ARP200101053A ARP200101053A AR118674A1 AR 118674 A1 AR118674 A1 AR 118674A1 AR P200101053 A ARP200101053 A AR P200101053A AR P200101053 A ARP200101053 A AR P200101053A AR 118674 A1 AR118674 A1 AR 118674A1
Authority
AR
Argentina
Prior art keywords
production
fenyl
ethylamine
substitute
alkanamide derivatives
Prior art date
Application number
ARP200101053A
Other languages
English (en)
Inventor
Erwin Waldvogel
Christoph Imboden
Matthias Riepl
Michael Wolberg
Wolfgang Skranc
Original Assignee
Newron Pharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newron Pharm Spa filed Critical Newron Pharm Spa
Publication of AR118674A1 publication Critical patent/AR118674A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/08—Preparation of carboxylic acid nitriles by addition of hydrogen cyanide or salts thereof to unsaturated compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/36—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by hydroxy groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente se refiere a un proceso para la producción de derivados de 2-[2-(fenil)etilamino]alcanamida sustituidos de la fórmula (1), en particular 2-[2-(3-butoxifenil)-etilamino]-N,N-dimetilacetamida, en altos rendimientos con muy alta pureza química. La presente se refiere a un proceso para preparar un compuesto de la fórmula (1) o una sal farmacéuticamente aceptable del mismo.
ARP200101053A 2019-04-17 2020-04-15 Proceso para la producción de derivados de 2-[2-(fenil)etilamino]alcanamida sustituidos AR118674A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19169714.3A EP3725768A1 (en) 2019-04-17 2019-04-17 Process for the production of substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives

Publications (1)

Publication Number Publication Date
AR118674A1 true AR118674A1 (es) 2021-10-20

Family

ID=66217869

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200101053A AR118674A1 (es) 2019-04-17 2020-04-15 Proceso para la producción de derivados de 2-[2-(fenil)etilamino]alcanamida sustituidos

Country Status (14)

Country Link
US (1) US20220177417A1 (es)
EP (2) EP3725768A1 (es)
JP (1) JP2022529916A (es)
KR (1) KR20210154206A (es)
CN (1) CN113784944A (es)
AR (1) AR118674A1 (es)
AU (1) AU2020259726A1 (es)
BR (1) BR112021020599A2 (es)
CA (1) CA3136845A1 (es)
IL (1) IL287228A (es)
MA (1) MA55710A (es)
MX (1) MX2021012713A (es)
SG (1) SG11202111378SA (es)
WO (1) WO2020212227A1 (es)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127559D0 (en) * 2001-11-16 2002-01-09 Syngenta Participations Ag Organic compounds
PT1572214E (pt) * 2002-12-10 2010-05-06 Pfizer Morfolina derivados para utilização como agonistas da dopamina no tratamento da disfunção sexual i.a.
JP4795965B2 (ja) * 2003-11-12 2011-10-19 エルジー・ライフ・サイエンシーズ・リミテッド メラノコルチン受容体のアゴニスト
KR101380137B1 (ko) * 2005-12-22 2014-04-11 뉴론 파마슈티칼즈 에스. 피. 에이. 칼슘 및/또는 나트륨 채널 조절제로서 2-페닐에틸아미노유도체
US8183413B2 (en) * 2006-01-20 2012-05-22 Kaneka Corporation Process for production of β-amino-α-hydroxy carboxamide derivative
NO2155663T3 (es) 2007-06-15 2018-04-28
KR101709498B1 (ko) * 2007-12-11 2017-02-23 뉴론 파마슈티칼즈 에스. 피. 에이. 고순도의 ２­［４­（３­ 또는 ２­플루오로벤질옥시）벤질아미노］프로판아미드의 제조방법
PT2723710T (pt) 2011-06-27 2016-11-14 Newron Pharm Spa Derivados fluorados de arilalquilaminocarboxamida
CN105518001A (zh) * 2013-07-09 2016-04-20 拜耳制药股份公司 Bet蛋白抑制性的改性的二氢喹喔啉酮类化合物和二氢吡啶并吡嗪酮类化合物
CN105801437A (zh) * 2016-03-31 2016-07-27 常州大学 一种(甲基氨基)(苯基)甲醇的合成方法
CN114249668A (zh) * 2020-09-25 2022-03-29 鲁南制药集团股份有限公司 一种唑吡坦中间体n,n-二甲基-2-氧乙酰胺的制备方法

Also Published As

Publication number Publication date
AU2020259726A1 (en) 2021-12-09
CN113784944A (zh) 2021-12-10
IL287228A (en) 2021-12-01
US20220177417A1 (en) 2022-06-09
BR112021020599A2 (pt) 2021-12-07
MA55710A (fr) 2022-02-23
EP3956295A1 (en) 2022-02-23
MX2021012713A (es) 2021-11-12
TW202104164A (zh) 2021-02-01
WO2020212227A1 (en) 2020-10-22
SG11202111378SA (en) 2021-11-29
KR20210154206A (ko) 2021-12-20
EP3725768A1 (en) 2020-10-21
CA3136845A1 (en) 2020-10-22
JP2022529916A (ja) 2022-06-27

Similar Documents

Publication Publication Date Title
CU20210002A7 (es) Derivados de 3-(5-hidroxi-1-oxoisoindolin-2-il)piperidina-2,6-diona y su uso en el tratamiento de trastornos dependientes de la proteína con dedos de zinc 2 de la familia ikaros (ikzf2)
CY1123817T1 (el) Μεθοδος για την παρασκευη ενωσεων που ειναι χρησιμες ως αναστολεις sglt
ECSP20013248A (es) Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos
AR114631A1 (es) Métodos e intermedios para preparar compuestos de piridina
JP2017537940A5 (es)
JP2021505614A5 (es)
MX2018009944A (es) Procedimiento para la preparacion del acido 4-fenil-5-alcoxicarbon il-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]3-oxo-5,6,8,8a- tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxilico.
ES2181663T3 (es) Procedimiento para la preparacion de citalopram puro.
BR0214675A (pt) Novos compostos e seu uso em medicina, processo para seu preparo e composições farmacêuticas contendo os mesmos
MA48798B1 (fr) Procédé de production d'ozanimod
AR095727A1 (es) Preparación de intermediarios de pirimidina
AR118647A1 (es) Proceso de preparación de 2-(3,5-diclorofenil)-6-benzoxazolcarboxilato de 1-deoxi-1-metilamino-d-glucitol
CO6480931A2 (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas.
CO2020013806A2 (es) Forma cristalina de tetracloruro de trietilentetramina y usos farmacéuticos de la misma
AR117920A1 (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana
AR064465A1 (es) Procesopatra preparar (1r, 2s, 5s) -n- [(1s)]-3- amino-1- ( ciclobutimetil) -2,3- dioxopropil] -3- [2s)-2- [[[(1,1- dimetiletil) amino]- carbonil] amino ]-3,3- dimetil -1- oxobutil] 6,6- dimetil-3- azabicoiclo (3.1.0] hexan -2- carboxamida
CO2018007008A2 (es) "procesos mejorados para la preparación de osimertinib (azd9291) o una sal del mismo y "azd9291 anilina" o una sal del mismo"
WO2020016847A3 (en) Purification process for preparation of eribulin and intermediates thereof
CL2022000904A1 (es) Proceso para la preparación de compuestos representados por las fórmulas iv, vii y ia; y un polimorfo del compuesto de fórmula ia (div. sol. 202001814).
AR118674A1 (es) Proceso para la producción de derivados de 2-[2-(fenil)etilamino]alcanamida sustituidos
ECSP22022403A (es) Proceso industrial para la preparación de estetrol de alta pureza
AR081514A1 (es) El compuesto 4-[etil(dimetil)amonio]butanoato, el metodo para la preparacion del mismo y el uso en el tratamiento de la enfermedad cardiovascular
AR075340A1 (es) 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a,formas cristalinas 1, 2 y 3, proceso para su preparacion, composicion farmaceutica que lo comprende y su uso para la preparacion de un medicamento util para el tratamiento de enfermedades inflamatorias
AR111465A1 (es) Método para la purificación de anticuerpos análogos por el uso de cromatografía de intercambio de cationes
CU20220023A7 (es) Derivados de 2-azaspiro[3,4]octano como agonistas de m4